Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study Research Letter
| Authors: | DiNardo, C. D.; De Botton, S.; Pollyea, D. A.; Stone, R. M.; Altman, J. K.; Fathi, A. T.; Limsakun, T.; Liang, M.; Choe, S.; Hossain, M.; Tron, A. E.; Meng, Q.; Kapsalis, S. M.; Pandya, S. S.; Stein, E. M. |
| Title: | Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study |
| Keywords: | clinical trial; pyridines; hematologic neoplasms; phase 1 clinical trial; hematologic disease; pyridine derivative; humans; human; diamine; diamines; vorasidenib |
| Journal Title: | American Journal of Hematology |
| Volume: | 98 |
| Issue: | 9 |
| ISSN: | 0361-8609 |
| Publisher: | John Wiley & Sons, Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | E233 |
| End Page: | E236 |
| Language: | English |
| DOI: | 10.1002/ajh.27005 |
| PUBMED: | 37354069 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Source: Scopus |
